Stage iiib lung cancer ajcc v8 Trials in Duarte, United States
Conditions / Stage iiib lung cancer ajcc v8 / Duarte, United States
Stage iiib lung cancer ajcc v8 is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04428905 | Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04227028 | Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05136846 | Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer | RECRUITING | PHASE1 |
| NCT03902535 | Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers | COMPLETED | — |
| NCT05166616 | Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT04929041 | Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative | SUSPENDED | PHASE2/PHASE3 |
| NCT02194738 | Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) | ACTIVE_NOT_RECRUITING | — |
| NCT04267848 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) | RECRUITING | — |
| NCT04819997 | A Nurse-Led Intervention for Fear of Progression in Advanced Cancer | ACTIVE_NOT_RECRUITING | NA |
| NCT05213078 | Family Caregivers in Underserved Populations Providing Complex Cancer Care | COMPLETED | NA |